SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-17-013626
Filing Date
2017-03-28
Accepted
2017-03-28 17:19:31
Documents
66
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 ASTERIAS BIOTHERAPEUTICS, INC 10-K 12-31-2016 form10k.htm 10-K 1433360
2 EXHIBIT 10.24 ex10_24.htm EX-10.24 43935
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2659
4 EXHIBIT 31 ex31.htm EX-31 12815
5 EXHIBIT 32 ex32.htm EX-32 4798
12 image0.jpg GRAPHIC 112088
  Complete submission text file 0001140361-17-013626.txt   7290832

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ast-20161231.xml EX-101.INS 1080106
7 XBRL TAXONOMY EXTENSION SCHEMA ast-20161231.xsd EX-101.SCH 68325
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20161231_cal.xml EX-101.CAL 71894
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20161231_def.xml EX-101.DEF 310504
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20161231_lab.xml EX-101.LAB 950202
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20161231_pre.xml EX-101.PRE 514385
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

IRS No.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36646 | Film No.: 17719879
SIC: 2836 Biological Products, (No Diagnostic Substances)